Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Miaorong She"'
Autor:
Xilin CHEN, Miaorong SHE
Publikováno v:
Chinese Journal of Lung Cancer, Vol 12, Iss 1, Pp 3-7 (2009)
Externí odkaz:
https://doaj.org/article/2ea99ab6794545149a82c871be745e57
Autor:
Yi Le, Jinggao Li, Miaorong She, Maohua Zhou, Yanjie He, Kunyuan Guo, Xin-qing Niu, Xilin Chen
Publikováno v:
Cancer Letters. 318:173-179
Leukemic stem cells (LSCs) play the central role in the relapse and refractory of acute myeloid leukemia (AML) and highlight the critical need for the new therapeutic strategies to directly target the LSC population. However, relatively little is kno
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:2902-2909
Anaplastic thyroid cancer (ATC) is extremely aggressive, and no effective treatment is available. Combretastatin A4 phosphate (CA4P), a vascular disrupting agent, has limited activity against ATC in a clinical trial, and so does paclitaxel.We hypothe
Publikováno v:
Cancer Research. 65:3671-3681
Farnesyltransferase inhibitors (FTIs) possess antitumor activity. Based on recent findings, we hypothesized that FTIs induce reactive oxygen species (ROS) that damage DNA, leading to DNA damage responses. To test this hypothesis, we investigated the
Autor:
Miaorong, She, Xilin, Chen
Publikováno v:
Zhongguo fei ai za zhi = Chinese journal of lung cancer. 12(1)
Publikováno v:
Cancer biologytherapy. 5(3)
Our previous studies demonstrated that manumycin A, a farnesyltransferase inhibitor, induced apoptosis of anaplastic thyroid cancer cells via the intrinsic apoptosis pathway and induced reactive oxygen species (ROS), which mediated DNA damage. In thi
Autor:
Sai Ching J. Yeung, Miaorong She
Publikováno v:
Cancer letters. 238(2)
We previously showed that the in vivo anticancer effects of a combination of manumycin (a farnesyltransferase inhibitor) and paclitaxel (a microtubule inhibitor) against anaplastic thyroid carcinoma (ATC) were partially due to inhibition of angiogene
Publikováno v:
OncoTargets and therapy
Jing-Gao Li,1,* Miao-Rong She,2,* Ci-Yong Lu,3 Shan-Shan Wei,2 Ping-Fang Xia,2 Ze-Sheng Lu,2 Qi Peng2 1Department of Nephrology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 2Department of Hematology, Guangdong General Hospital, Guangdong A
Publikováno v:
Blood. 118:4738-4738
Abstract 4738 Acute myeloid leukemia (AML) is a serious and often lethal hematopoietic malignant disease arising from stem cells. LSCs play the central role in the relapse and refractory of AML and highlight the critical need for the new therapeutic